Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2002 2
2003 2
2004 2
2005 2
2006 6
2007 3
2008 5
2009 6
2010 7
2011 9
2012 5
2013 4
2014 9
2015 2
2016 3
2017 6
2018 8
2019 7
2020 10
2021 10
2022 4
2023 3
2024 8
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

113 results

Results by year

Filters applied: . Clear all
Page 1
Brain atrophy patterns in anti-IgLON5 disease.
Yogeshwar SM, Bartels F, Grüter T, Muñiz-Castrillo S, Picard G, Crijnen YS, Bernard E, Heidbreder A, Zekeridou A, Ringelstein M, Kraft A, Kovac S, Wandinger KP, de Vries JM, Boon AJW, Veenbergen S, Geis C, Penner L, Melzer N, Leypoldt F, Blaabjerg M, Pittock SJ, Gaig C, Sabater L, Santamaria J, Graus F, Dalmau J, Prüss H, Höftberger R, Schreiner B, McKeon A, Lewerenz J, Irani S, Mignot E, Titulaer MJ, Ayzenberg I, Honnorat J, Finke C; IgLON5 Imaging Consortium. Yogeshwar SM, et al. Brain. 2025 Jul 12:awaf256. doi: 10.1093/brain/awaf256. Online ahead of print. Brain. 2025. PMID: 40650880
Imaging synucleinopathies.
Brooks DJ, Tambasco N. Brooks DJ, et al. Among authors: tambasco n. Mov Disord. 2016 Jun;31(6):814-29. doi: 10.1002/mds.26547. Epub 2016 Feb 16. Mov Disord. 2016. PMID: 26879635 Review.
HLA-DQB1*05 subtypes and not DRB1*10:01 mediates risk in anti-IgLON5 disease.
Yogeshwar SM, Muñiz-Castrillo S, Sabater L, Peris-Sempere V, Mallajosyula V, Luo G, Yan H, Yu E, Zhang J, Lin L, Fagundes Bueno F, Ji X, Picard G, Rogemond V, Pinto AL, Heidbreder A, Höftberger R, Graus F, Dalmau J, Santamaria J, Iranzo A, Schreiner B, Giannoccaro MP, Liguori R, Shimohata T, Kimura A, Ono Y, Binks S, Mariotto S, Dinoto A, Bonello M, Hartmann CJ, Tambasco N, Nigro P, Prüss H, McKeon A, Davis MM, Irani SR, Honnorat J, Gaig C, Finke C, Mignot E. Yogeshwar SM, et al. Among authors: tambasco n. Brain. 2024 Jul 5;147(7):2579-2592. doi: 10.1093/brain/awae048. Brain. 2024. PMID: 38425314 Free PMC article.
Increased glucosylsphingosine levels and Gaucher disease in GBA1-associated Parkinson's disease.
Marano M, Zizzo C, Malaguti MC, Bacchin R, Cavallieri F, De Micco R, Spagnolo F, Bentivoglio AR, Schirinzi T, Bovenzi R, Ramat S, Erro R, Sorrentino C, Sucapane P, Pilotto A, Lupini A, Magliozzi A, Di Vico I, Carecchio M, Bonato G, Cilia R, Colucci F, Tamma F, Caputo E, Mostile G, Arabia G, Modugno N, Zibetti M, Ceravolo MG, Tambasco N, Cossu G, Valzania F, Manganotti P, Di Lazzaro V, Zappia M, Fabbrini G, Tinazzi M, Tessitore A, Duro G, Di Fonzo A. Marano M, et al. Among authors: tambasco n. Parkinsonism Relat Disord. 2024 Jul;124:107023. doi: 10.1016/j.parkreldis.2024.107023. Epub 2024 Jun 1. Parkinsonism Relat Disord. 2024. PMID: 38843618 Free article.
Family History in Parkinson's Disease: A National Cross-Sectional Study.
Arienti F, Casazza G, Franco G, Lazzeri G, Monfrini E, Di Maio A, Erro R, Barone P, Tamma F, Caputo E, Volontè MA, Cacciaguerra L, Pilotto A, Padovani A, Comi C, Magistrelli L, Valzania F, Cavallieri F, Avanzino L, Marchese R, Sensi M, Carroli G, Eleopra R, Cilia R, Spagnolo F, Tessitore A, De Micco R, Ceravolo R, Palermo G, Malaguti MC, Lopiano L, Tocco P, Sorbera C, Tinazzi M, Ciammola A, Ottaviani D, Valente EM, Albanese A, Blandini F, Canesi M, Antonini A, Carecchio M, Fetoni V, Colosimo C, Volpe D, Tambasco N, Cossu G, Zappia M; Italian Study Group on Family History in PD; Di Fonzo A. Arienti F, et al. Among authors: tambasco n. Mov Disord Clin Pract. 2024 Nov;11(11):1434-1440. doi: 10.1002/mdc3.14206. Epub 2024 Sep 13. Mov Disord Clin Pract. 2024. PMID: 39269187 Free PMC article.
Early Treatment With Intravenous Immunoglobulins and Outcomes of Patients With Anti-IgLON5 Disease.
Grüter T, Gaig C, Crijnen YS, Titulaer MJ, Sabater L, Heidbreder A, Dargvainiene J, Tietz A, Kovac S, Dik A, Erro ME, Lewerenz J, Kraft A, Seifert F, Höftberger R, Thaler FS, de Azevedo L, Wickel J, de Vries JM, Boon AJW, van Steenhoven RW, Gold R, Wandinger KP, Kuhlenbäumer G, Dalmau JO, Leypoldt F, Graus F, Ayzenberg I; Anti-IgLON5 Disease Study Group. Grüter T, et al. JAMA Neurol. 2025 Oct 1;82(10):1040-1047. doi: 10.1001/jamaneurol.2025.2574. JAMA Neurol. 2025. PMID: 40758377
Levodopa treatment in Parkinson's disease: earlier or later?
Paolini Paoletti F, Tambasco N, Parnetti L. Paolini Paoletti F, et al. Among authors: tambasco n. Ann Transl Med. 2019 Sep;7(Suppl 6):S189. doi: 10.21037/atm.2019.07.36. Ann Transl Med. 2019. PMID: 31656768 Free PMC article. No abstract available.
113 results